Comparative Efficacy of Vedolizumab and Adalimumab in Ulcerative Colitis Patients Previously Treated With Infliximab
- Favale, Agnese
- Onali, Sara
- Caprioli, Flavio
- Pugliese, Daniela
- Armuzzi, Alessandro
- Macaluso, Fabio Salvatore
- Orlando, Ambrogio
- Viola, Anna
- Fries, Walter
- Rispo, Antonio
- Castiglione, Fabiana
- Mocci, Giammarco
- Chicco, Fabio
- Usai, Paolo
- Calabrese, Emma
- Biancone, Livia
- Monteleone, Giovanni
- Fantini, Massimo Claudio
Publication date
April 2019
DOIAbstract
Adalimumab (ADA) and vedolizumab (VDZ) have shown efficacy in moderate to severe ulcerative colitis (UC) patients who failed infliximab (IFX). Although, a comparative efficacy evaluation of ADA and VDZ in this clinical setting is currently missing
Add to ORKG